COMMUNIQUÉS West-GlobeNewswire

The Alliance for Regenerative Medicine Announces 2019 Cell & Gene Therapies State of the Industry Briefing

04/12/2018 - 16:46

WASHINGTON, D.C., Dec. 04, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- The Alliance for Regenerative Medicine (ARM), the international advocacy organization representing the cell and gene therapies and broader [...]

Peter Buhl Jensen, CEO in Oncology Venture buys shares in the Company

04/12/2018 - 16:19

Company Announcement Peter Buhl Jensen, CEO in Oncology Venture buys shares in the Company Hoersholm, Denmark – December 4, 2018 – Oncology Venture A/S (OV:ST) announces that CEO Peter Buhl Jensen, through Buhl Krone [...]

Precipio Announces $1.2 Million Securities Purchase Agreement With Participation from Members of Its Board of Directors, and other Investors

04/12/2018 - 15:15

NEW HAVEN, Conn., Dec. 04, 2018 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. ( NASDAQ: PRPO ), announced today that it has entered into a $1.2 million Securities Purchase Agreement with several [...]

Translate Bio Expands Patent Portfolio with Newly Issued U.S. Patent Relating to Its Messenger RNA (mRNA) Therapeutics Platform (MRT™)

04/12/2018 - 15:15

Patent Supports Foundational Intellectual Property and Pioneering Work in Liver Delivery for mRNA Therapeutics LEXINGTON, Mass., Dec. 04, 2018 (GLOBE NEWSWIRE) -- Translate Bio (Nasdaq: TBIO), a clinical-stage messenger [...]

Inspire Medical Systems, Inc. Announces Proposed Offering of Common Stock

04/12/2018 - 15:14

MINNEAPOLIS, Dec. 04, 2018 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire”), a medical technology company focused on the development and commercialization of innovative and minimally invasive [...]

Admera Health Adds Clinical Genomics Expert, Dr. Ruben Bonilla-Guerrero, to Management Team

04/12/2018 - 15:13

SOUTH PLAINFIELD, N.J., Dec. 04, 2018 (GLOBE NEWSWIRE) -- Admera Health, a molecular diagnostic company, welcomes Dr. Ruben Bonilla-Guerrero as Medical Director to the company. Ruben Bonilla-Guerrero obtained his M.D. [...]

New Proximity Systems Open-Arm Cabinet Meets Space Constraints of Shrinking Patient Rooms

04/12/2018 - 15:00

Flexible workstation mount is ergonomically designed to improve ability of hospital staff to interact with patients TOMBALL, Texas, Dec. 04, 2018 (GLOBE NEWSWIRE) -- Proximity Systems, Inc., the leading provider of [...]

Cellectar Initiates Cohort 6 of Phase 1b Trial Evaluating CLR 131 in Relapsed/Refractory Multiple Myeloma

04/12/2018 - 14:30

Patient enrolled at highest fractionated two-dose regimen to date FLORHAM PARK, N.J., Dec. 04, 2018 (GLOBE NEWSWIRE) -- Cellectar Biosciences (Nasdaq: CLRB), a clinical-stage biopharmaceutical company focused on the [...]

Ritter Pharmaceuticals Reaches Halfway Mark for Enrollment in Pivotal Phase 3 Clinical Trial of RP-G28 in Patients with Lactose Intolerance

04/12/2018 - 14:30

Full Enrollment on Target for Q2 2019 with Data Readout Expected in the Second Half of 2019 LOS ANGELES, Dec. 04, 2018 (GLOBE NEWSWIRE) -- Ritter Pharmaceuticals, Inc. (Nasdaq: RTTR) (“Ritter Pharmaceuticals” or the “ [...]

Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

04/12/2018 - 14:30

BRIDGEWATER, N.J., Dec. 04, 2018 (GLOBE NEWSWIRE) -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced [...]

PSIQ Grants Exclusive Distribution Rights for Mexico and Argentina With First Year Minimum Guarantee of $500,000 and 20% Growth Per Year Thereafter

04/12/2018 - 14:30

SUNRISE, Fla., Dec. 04, 2018 (GLOBE NEWSWIRE) -- Profile Solutions, Inc. (OTC Pink: PSIQ) announces it has granted the exclusive distribution rights for Mexico and Argentina to RCS International Investments, Corp. (“RCS [...]

XBiotech annonce la réussite de l'audit BPF

04/12/2018 - 14:18

Le premier audit dans la nouvelle usine de fabrication de la société montre sa conformité aux directives BPF AUSTIN, Texas, 04 déc. 2018 (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ:XBIT) a annoncé aujourd'hui le succès de [...]

Orion acquires sales and distribution rights for certain European Countries for Parkinson's disease drug Stalevo

04/12/2018 - 14:01

ORION CORPORATION PRESS RELEASE 4 DECEMBER 2018 at 15.00 EET Orion acquires sales and distribution rights for certain European Countries for Parkinson's disease drug Stalevo Orion Corporation and Novartis Pharma AG have [...]

HempAmericana Upgrades CBD Quality and Output Capacity at Primary Facility Ahead of Full-Scale Production

04/12/2018 - 14:00

NEW YORK, Dec. 04, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE – HempAmericana, Inc. (OTC: HMPQ) (“HempAmericana” or the “Company”) is excited to announce the installation of a new high-precision Solvent Recovery Machine [...]

Director/PDMR Shareholding

04/12/2018 - 14:00

DXS INTERNATIONAL PLC Director Dealing The Board of DXS International plc (the “Company”), the NEX quoted clinical decision support developer and supplier of clinical decision support systems is pleased to confirm that [...]

Inovio Announces Initiation of “MD Anderson’s HPV-Related Cancers Moon Shot” Phase 2 Trial in New HPV Indications

04/12/2018 - 14:00

Phase 2 cancer study will evaluate T cell-activating immunotherapy MEDI0457 with MedImmune’s durvalumab targeting several HPV-related cancers PLYMOUTH MEETING, Pa., Dec. 04, 2018 (GLOBE NEWSWIRE) -- Inovio [...]

Nemaura Successfully Completes Clinical Studies for SugarBEAT® FDA De-Novo 510(k) Submission

04/12/2018 - 14:00

LOUGHBOROUGH, England. Nemaura Medical Inc. (NASDAQ: NMRD), a medical technology company developing sugarBEAT® as a non-invasive affordable and flexible Continuous Glucose Monitor (CGM) for use by people with diabetes [...]

AzurRx BioPharma to Present at Upcoming Investor Conferences

04/12/2018 - 14:00

BROOKLYN, N.Y., Dec. 04, 2018 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (NASDAQ: AZRX ) (“AzurRx” or the “Company”), a company specializing in the development of non-systemic, recombinant therapies for gastrointestinal [...]

Interface Biologics Announces New V.P., Business Development

04/12/2018 - 14:00

TORONTO, Dec. 04, 2018 (GLOBE NEWSWIRE) -- Interface Biologics Inc. (“IBI”), a privately held, commercial stage developer of innovative material science technologies for Medtech and Pharmaceutical applications, is [...]